Terms: = Endocrine gland cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Treatment
13 results:
1. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
[TBL] [Abstract] [Full Text] [Related]
2. SUMO Modification of PAF1/PD2 Enables pml Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma.
Rauth S; Karmakar S; Shah A; Seshacharyulu P; Nimmakayala RK; Ganguly K; Bhatia R; Muniyan S; Kumar S; Dutta S; Lin C; Datta K; Batra SK; Ponnusamy MP
Mol Cell Biol; 2021 Nov; 41(12):e0013521. PubMed ID: 34570619
[TBL] [Abstract] [Full Text] [Related]
3. pml hyposumoylation is responsible for the resistance of pancreatic cancer.
Swayden M; Alzeeb G; Masoud R; Berthois Y; Audebert S; Camoin L; Hannouche L; Vachon H; Gayet O; Bigonnet M; Roques J; Silvy F; Carrier A; Dusetti N; Iovanna JL; Soubeyran P
FASEB J; 2019 Nov; 33(11):12447-12463. PubMed ID: 31557059
[TBL] [Abstract] [Full Text] [Related]
4. pml-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian cancers.
Gentric G; Kieffer Y; Mieulet V; Goundiam O; Bonneau C; Nemati F; Hurbain I; Raposo G; Popova T; Stern MH; Lallemand-Breitenbach V; Müller S; Cañeque T; Rodriguez R; Vincent-Salomon A; de Thé H; Rossignol R; Mechta-Grigoriou F
Cell Metab; 2019 Jan; 29(1):156-173.e10. PubMed ID: 30244973
[TBL] [Abstract] [Full Text] [Related]
5. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation.
Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R
Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707
[TBL] [Abstract] [Full Text] [Related]
6. [A rare case of acute promyelocytic leukemia accompanied by benign craniopharyngioma].
Zhang Q; Yang H; Zhu CY; Niu JH; Xu YY; Wang N; Zhu HY; Yu L; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):660-5. PubMed ID: 24989272
[TBL] [Abstract] [Full Text] [Related]
7. SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide.
Singh S; Pradhan AK; Chakraborty S
Biochim Biophys Acta; 2013 Oct; 1833(10):2357-68. PubMed ID: 23770046
[TBL] [Abstract] [Full Text] [Related]
8. SnoN/SkiL, a TGFβ signaling mediator: a participant in autophagy induced by arsenic trioxide.
Raffoul F; Campla C; Nanjundan M
Autophagy; 2010 Oct; 6(7):955-7. PubMed ID: 20699661
[TBL] [Abstract] [Full Text] [Related]
9. Localisation and surgical treatment of insulinomas.
Gourgiotis S; Moustafellos P; Zavos A; Stratopoulos C; Vericouki C; Hadjiyannakis E
Int J Clin Pract; 2007 Apr; 61(4):558-61. PubMed ID: 17394431
[TBL] [Abstract] [Full Text] [Related]
10. Molecular events in follicular thyroid tumors.
Kroll TG
Cancer Treat Res; 2004; 122():85-105. PubMed ID: 16209039
[TBL] [Abstract] [Full Text] [Related]
11. Testicular relapse of acute promyelocytic leukemia after allogeneic BMT.
Forrest DL; Dalal BI; Naiman SC; Horsman DE; Berry BR; Parslow MI; Singh CP; Benny WB; Barnett MJ
Bone Marrow Transplant; 1997 Oct; 20(8):689-90. PubMed ID: 9383233
[TBL] [Abstract] [Full Text] [Related]
12. Topotecan and pml: the limits of pharmaceutical industry research.
Learned J
Notes Undergr; 1996 Sep; (No 33):1-3. PubMed ID: 11363913
[TBL] [Abstract] [Full Text] [Related]
13. Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature.
Hoffmann L; Möller P; Pedersen-Bjergaard J; Waage A; Pedersen M; Hirsch FR
Ann Oncol; 1995 Oct; 6(8):781-8. PubMed ID: 8589015
[TBL] [Abstract] [Full Text] [Related]